These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 28371465)

  • 41. Impact of Implementing the Paris System for Reporting Urinary Cytology: A Single-institutional Experience With Emphasis on Diagnostic Yield of High-grade Urothelial Carcinoma and Low-grade Urothelial Neoplasm.
    Koh HH; Lee MJ; Park NJ; Kim HS; Oh YL
    Anticancer Res; 2020 Jun; 40(6):3477-3484. PubMed ID: 32487647
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Application of the Paris Reporting System for Urine Cytology: The Three-Year Experience of a Single Tertiary Care Institute in Thailand.
    Phruttinarakorn B; Plumworasawat S; Kayankarnnavee J; Lualon J; Pongtippan A
    Acta Cytol; 2022; 66(2):134-141. PubMed ID: 34999581
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of bacillus Calmette-Guerin intravesical therapy on the diagnostic efficacy of The Paris System for Reporting Urinary Cytology in patients with high-grade bladder cancer.
    Hermans J; Jokisch F; Volz Y; Eismann L; Pfitzinger P; Ebner B; Weinhold P; Schlenker B; Stief CG; Tritschler S; Schulz GB
    Cancer Cytopathol; 2022 Apr; 130(4):294-302. PubMed ID: 34919338
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cyto-histo correlation and false-negative urine: Before and after the Paris system for reporting urinary cytology.
    Yuan L; Gero M; Zia S; Aryal SC; Shetty S; Reynolds JP
    Diagn Cytopathol; 2022 Aug; 50(8):404-410. PubMed ID: 35652594
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Digital image analysis supports a nuclear-to-cytoplasmic ratio cutoff value of 0.5 for atypical urothelial cells.
    Hang JF; Charu V; Zhang ML; VandenBussche CJ
    Cancer Cytopathol; 2017 Sep; 125(9):710-716. PubMed ID: 28581671
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunocytochemical staining for p53 and Ki-67 helps to characterise urothelial cells in urine cytology.
    Courtade-Saïdi M; Aziza J; d'Aure D; Bérard E; Evrard S; Basset C; Lacoste-Collin L
    Cytopathology; 2016 Dec; 27(6):456-464. PubMed ID: 27873391
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Should the BK polyomavirus cytopathic effect be best classified as atypical or benign in urine cytology specimens?
    Allison DB; Olson MT; Lilo M; Zhang ML; Rosenthal DL; VandenBussche CJ
    Cancer Cytopathol; 2016 Jun; 124(6):436-42. PubMed ID: 26929126
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic implications of aberrations in p16/pRb pathway in urothelial bladder carcinomas: a multivariate analysis including p53 expression and proliferation markers.
    Korkolopoulou P; Christodoulou P; Lazaris A; Thomas-Tsagli E; Kapralos P; Papanikolaou A; Kalliteraki I; Davaris P
    Eur Urol; 2001 Feb; 39(2):167-77. PubMed ID: 11223676
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Comparison of perioperative methylene blue-stained and permanent Papanicolaou-stained urine cytology to detect patients with high-grade urothelial cancer or the urinary bladder. Part 1].
    Rossi R; Jaeger T; Börgermann C; Furtkamp C; Moos Stahl R; Rübben H; vom Dorp F
    Urologe A; 2007 Sep; 46(9):1145-7. PubMed ID: 17661004
    [TBL] [Abstract][Full Text] [Related]  

  • 50. ThinPrep® imaging system-assisted vs manual screening of urinary cytology slides in the detection of the "suspicious for high-grade urothelial carcinoma" category.
    Piaton E; Prat JJ; Nennig C; Hutin K; Colombel M; Ruffion A
    Cytopathology; 2022 Nov; 33(6):716-724. PubMed ID: 36004492
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Two-year study on the application of the Paris system for urinary cytology in a cancer centre.
    de Paula R; Oliveira A; Nunes W; Bovolim G; Domingos T; De Brot L; Bezerra S; Cunha I; Morini M; Saieg M
    Cytopathology; 2020 Jan; 31(1):41-46. PubMed ID: 31654587
    [TBL] [Abstract][Full Text] [Related]  

  • 52. uCyt+/ImmunoCyt and cytology in the detection of urothelial carcinoma: an update on 7422 analyses.
    Comploj E; Mian C; Ambrosini-Spaltro A; Dechet C; Palermo S; Trenti E; Lodde M; Horninger W; Pycha A
    Cancer Cytopathol; 2013 Jul; 121(7):392-7. PubMed ID: 23495066
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The combined application of urinary liquid-based cytology with fluorescence in situ hybridization and p16/Ki-67 dual immunostaining is valuable for improving the early diagnosis of upper tract urothelial carcinomas.
    Sun X; Liu X; Xia M; Yang S; Fei L; Zhang M; Ma H; Wang L; Chen S; Yu L
    Diagn Cytopathol; 2017 Oct; 45(10):895-902. PubMed ID: 28799728
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of the Paris System in atypical urinary cytology.
    Mikou P; Lenos M; Papaioannou D; Vrettou K; Trigka EA; Sousouris S; Constantinides C
    Cytopathology; 2018 Dec; 29(6):545-549. PubMed ID: 30066427
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Johns Hopkins Hospital template for urologic cytology samples: part I-creating the template.
    Rosenthal DL; Vandenbussche CJ; Burroughs FH; Sathiyamoorthy S; Guan H; Owens C
    Cancer Cytopathol; 2013 Jan; 121(1):15-20. PubMed ID: 23192944
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diagnosis of urinary bladder urothelial carcinoma by immunocytology with p53, MCM5, MCM2 and Ki-67 antibodies using cell blocks derived from urine.
    Brisuda A; Háček J; Čechová M; Škapa P; Babjuk M
    Cytopathology; 2019 Sep; 30(5):510-518. PubMed ID: 30943322
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Should "suspicious for high-grade urothelial carcinoma" and "positive for high-grade urothelial carcinoma" remain separate categories?
    Nguyen L; Nilforoushan N; Krane JF; Bose S; Bakkar R
    Cancer Cytopathol; 2021 Feb; 129(2):156-163. PubMed ID: 33036060
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The application of the Johns Hopkins Hospital Template on urine cytology.
    Wu HH; Redelman M; Chen S; Grignon DJ; Cramer HM
    Diagn Cytopathol; 2015 Aug; 43(8):593-7. PubMed ID: 25721938
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intermediate-risk urothelial carcinoma: an unresolved problem?
    Pycha A; Lodde M; Comploj E; Negri G; Egarter-Vigl E; Vittadello F; Lusuardi L; Palermo S; Mian C
    Urology; 2004 Mar; 63(3):472-5. PubMed ID: 15028440
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Utility of the Paris System in Reporting Urine Cytology.
    Malviya K; Fernandes G; Naik L; Kothari K; Agnihotri M
    Acta Cytol; 2017; 61(2):145-152. PubMed ID: 28380477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.